Extension Analysis for context Medication

SourceURLVersionRealmTypeDescription
Medication
hl7.fhir.no.basis#2.1.2http://hl7.no/fhir/StructureDefinition/no-basis-prescriptiongroup|2.0.34.0.1no(complex)Part of norwegian standard for describing a prescription.

Profile Paths: Medication
hl7.fhir.au.base#currenthttp://hl7.org.au/fhir/StructureDefinition/medication-brand-name|4.1.14.0.1austringThis extension applies to the Medication, MedicationRequest, MedicationDispense amd MedicationStatement resources and is used to represent the brand name of a medication. This extension is not to be the sole representation of the medication concept; it shall not be used as a substitute for medication code (e.g. Medication.code or MedicationStatement.medicationCodeableConcept). If a system can only supply branded product information in text form, that information will be supplied in the text portion of that code e.g. code.text or medicationCodeableConcept.text. This extension only supports the name portion of a medication concept, not the branded product or product pack information. It is available for use for where a system needs to separate out the brand name string for handling or other processing.

Profile Paths: Medication
hl7.fhir.au.base#currenthttp://hl7.org.au/fhir/StructureDefinition/medication-generic-name|4.1.14.0.1austringThis extension applies to the Medication, MedicationRequest, MedicationDispense and MedicationStatement resources and is used to represent the generic name of a medication. The generic medication text name may not be the same as the subject medication (prescribed, dispensed or stated) but may be used to provide an additional or equivalent drug name that is a generic medication concept. This extension is not to be the sole representation of the medication concept; it shall not be used as a substitute for medication code (e.g. Medication.code or MedicationStatement.medicationCodeableConcept). If a system can only supply generic product information, and only in text form, that information will be supplied in the text portion of that code e.g. code.text or medicationCodeableConcept.text. This extension only supports the name portion of a medication concept, not the generic product or product pack information. It is available for use for where a system needs to separate out the generic name string for handling or other processing.

Profile Paths: Medication
hl7.fhir.au.base#currenthttp://hl7.org.au/fhir/StructureDefinition/medication-strength|4.1.14.0.1austringThis extension applies to the Medication resource and is used to represent the strength of a medication as text.

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-atc|0.1.04.3.0New ZealandCodeableConceptAnatomical Therapeutic Chemical (ATC) Classification - see https://www.who.int/tools/atc-ddd-toolkit/atc-classification

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-cal|0.1.04.3.0New Zealand(complex)Cautionary and Advisory Label

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-description|0.1.04.3.0New Zealand(complex)Specific NZMT descriptions that apply to this medication

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-funding|0.1.04.3.0New Zealand(complex)Core funding information specific to NZ. The extension can be added multiple times to a product for each PHARMAC schedule. These can be differentiated via the scheduleDate field.

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-funding-rule|0.1.04.3.0New Zealand(complex)Funding restriction information which complements the general funding information provided in the nzf-funding extension. The extension can be added multiple times to a product for each given rule as well as for each PHARMAC schedule. These can be differentiated via the scheduleDate field.

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-legalclass|0.1.04.3.0New Zealand(complex)Legal classification

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-link|0.1.04.3.0New ZealandReferenceReference to other information about this medication

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-medsafe|0.1.04.3.0New Zealand(complex)Medsafe package, reg situation and administration route details

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-nzmt-type|0.1.04.3.0New ZealandCodeableConceptThe NZ Medicines Terminology (NZMT) Data Class – MP (Medicinal Product), MPUU (Medicinal Product Unit of Use), MPP (Medicinal Product Pack), TP (Trade Product), TPUU (Trade Product Unit of Use), TPP (Trade Product Pack) or CTPP (Containered Trade Product Pack) – that the Medication is a member of.

Profile Paths: CodeableConcept.coding, Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-prescribe-by-brand|0.1.04.3.0New ZealandbooleanTrue if can be prescribed by brand

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-related-medication|0.1.04.3.0New Zealand(complex)A related medication within the NZMT hierarchy

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-supply-information|0.1.04.3.0New Zealand(complex)Information around the supply and availability of medications applied at each NZMT level. For example, when paracetamol tablets are in short supply an alert may be attached to the MP level medication along with the relevant details.

Profile Paths: Medication
hl7.org.nz.fhir.ig.formulary#currenthttp://hl7.org.nz/fhir/StructureDefinition/nzf-unapproved|0.1.04.3.0New ZealandbooleanTrue if this medication has not been approved by Medsafe and can be prescribed under section 29

Profile Paths: Medication
nictiz.fhir.nl.stu3.zib2017#2.2.15http://nictiz.nl/fhir/StructureDefinition/zib-Product-Description|2.0.23.0.2?stringA textual description of the type of medication (including relevant properties of the composition and preparation method if possible), which is only used if no coded indication from the G Standard is available (magistral preparation).

Profile Paths: Medication
ca.infoway.io.psca#1.0.1-alpha3http://prescribeit.ca/fhir/StructureDefinition/ext-medication-strength-description|1.0.04.0.1CanadastringProvides a textual description of the strength of the active ingredient(s) in the medication. This extension is published by PrescribeIT and recreated in this project to ease validation

Profile Paths: Medication
fhir.r4.ukcore.stu1#1.0.4https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-MedicationTradeFamily|1.0.04.0.1us(complex)This Extension is used to identify a Trade Family or brand associated with a Medication, in particular a Virtual Therapeutic Moiety (VTM).

Profile Paths: Medication
Medication.batch
hl7.fhir.uv.extensions.r4#1.0.0http://hl7.org/fhir/StructureDefinition/medication-manufacturingBatch|1.0.05.0.0uv(complex)The date at which the drug substance or drug product was manufactured. The specific operation/step in the process used to determine the date is specified by the manufacturingDateClassification element.
hl7.fhir.us.pq-cmc#currenthttp://hl7.org/fhir/us/pq-cmc/StructureDefinition/drug-product-manufacturing-batch|0.1.155.0.0us(complex)This profile defines the details of a batch of medicine.

Profile Paths: Medication.batch
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-actual-yield-dxpq|0.1.05.0.0uvQuantity
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-actual-yield-unfiltered-dxpq|0.1.05.0.0uvQuantity
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-batch-designation-dxpq|0.1.05.0.0uvCodeableConcept
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-batch-number-of-vials-dxpq|0.1.05.0.0uvpositiveInt
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-batch-release-date-dxpq|0.1.05.0.0uvdateTime
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-batch-retest-date-dxpq|0.1.05.0.0uvdateTime
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-batch-substance-batch-dxpq|0.1.05.0.0uvReference
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-instance-comment-dxpq|0.1.05.0.0uvstring
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-manufacturing-process-dxpq|0.1.05.0.0uvReference
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-packaging-date-dxpq|0.1.05.0.0uvdateTime
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-packaging-site-dxpq|0.1.05.0.0uvReference
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-table-footnote-dxpq|0.1.05.0.0uvstring
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-target-fill-weight-dxpq|0.1.05.0.0uvQuantity
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-test-comment-dxpq|0.1.05.0.0uvstring
Medication.code
hl7.fhir.uv.dx-pq#currenthttp://hl7.org/fhir/uv/dx-pq/StructureDefinition/Extension-medication-definition-dxpq|0.1.05.0.0uvReference
Medication.ingredient
jp-core.draft#1.0.7http://jpfhir.jp/fhir/core/Extension/StructureDefinition/JP_Medication_Ingredient_DrugNo|1.0.04.0.1?(complex)投与量が製剤単位か成分単位かを格納する拡張
Medication.ingredient.strength
jp-core.draft#1.0.7http://jpfhir.jp/fhir/core/Extension/StructureDefinition/JP_Medication_IngredientStrength_StrengthType|1.0.04.0.1?(complex)投与量が製剤単位か成分単位かを格納する拡張